The Use of Antidepressants, Anxiolytics, and Hypnotics in People with Type 2 Diabetes and Patterns Associated with Use: The Hoorn Diabetes Care System Cohort

Objective. With depression being present in approximately 20% of people with type 2 diabetes mellitus (T2DM), we expect equally frequent prescription of antidepressants, anxiolytics, and hypnotics. Nevertheless, prescription data in people with T2DM is missing and the effect of depression on glycaem...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biomed Res Int
Asıl Yazarlar: Mast, R., Rauh, S. P., Groeneveld, L., Koopman, A. D., Beulens, J. W. J., Jansen, A. P. D., Bremmer, M., van der Heijden, A. A. W. A., Elders, P. J., Dekker, J. M., Nijpels, G., Hugtenburg, J. G., Rutters, F.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi Publishing Corporation 2017
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5292378/
https://ncbi.nlm.nih.gov/pubmed/28232942
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/5134602
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller